venBio Partners LLC Long-Term Concentrated

CIK: 0001776382 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value ($000): $176,404 (100.0% shares, 0.0% debt)

Holdings (6)

PHVS PHARVARIS N V 65.6%

Value ($000) $115,751 Shares 4,639,304 Est. Cost $21.23 Unrealized +4.5%

ALMS ALUMIS INC 10.4%

Value ($000) $18,433 Shares 4,619,803 Est. Cost $9.90 Unrealized -58.4%

ALXO ALX ONCOLOGY HLDGS INC 10.1%

Value ($000) $17,751 Shares 9,699,925 Est. Cost $39.31 Unrealized -97.8%

HRMY HARMONY BIOSCIENCES HLDGS IN 7.6%

Value ($000) $13,482 Shares 489,194 Est. Cost $36.46 Unrealized -5.5%

LYEL LYELL IMMUNOPHARMA INC 4.4%

Value ($000) $7,689 Shares 473,479 Est. Cost $9.11 Unrealized +25.3%

ARTV ARTIVA BIOTHERAPEUTICS INC 1.9%

Value ($000) $3,298 Shares 1,148,975 Est. Cost $11.59 Unrealized -76.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PHVS	PHARVARIS N V	4,639,304	$115,751	65.6%	$21.23	+4.5%	COM	N69605108
ALMS	ALUMIS INC	4,619,803	$18,433	10.4%	$9.90	-58.4%	COM	022307102
ALXO	ALX ONCOLOGY HLDGS INC	9,699,925	$17,751	10.1%	$39.31	-97.8%	COM	00166B105
HRMY	HARMONY BIOSCIENCES HLDGS IN	489,194	$13,482	7.6%	$36.46	-5.5%	COM	413197104
LYEL	LYELL IMMUNOPHARMA INC	473,479	$7,689	4.4%	$9.11	+25.3%	COM NEW	55083R203
ARTV	ARTIVA BIOTHERAPEUTICS INC	1,148,975	$3,298	1.9%	$11.59	-76.9%	COM	04317A107